Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

    Explore existing data to uncover cancer risk insights, seeking to understand outcomes like survival and treatment response.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

    This grant supports researchers in analyzing existing data to understand cancer risk and related outcomes, aiming to address key scientific questions in cancer research.

    HHS-NIH11Due Nov 16, 2026· 15d$275,000

    Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

    The National Cancer Institute funds cancer epidemiology cohort research on cancer causes and survivorship, including cohort upkeep, follow-up, and data and biospecimen sharing; clinical trials are not allowed.

    HHS-NIH11Due Nov 5, 2026· 4d

    Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

    This grant supports investigator-initiated clinical trials to reduce cancer burden through early detection, prevention, and survivorship improvements.

    HHS-NIH11Due Nov 5, 2026· 4d

    Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

    Funding opportunity for cancer research innovations in statistical methods, epidemiology, survivorship, behaviors, healthcare, and implementation.

    HHS-NIH11Due Nov 5, 2026· 4d$1,250,000

    Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

    This grant funds projects to further develop and validate innovative technologies that advance cancer research or clinical care, focusing on technical improvements and rigorous validation for broad adoption.

    HHS-NIH11Forecasted Jun 4, 2027$300,000Forecasted